Use of ECT with treatment-resistant depressed patients at the National Institute of Mental Health

Am J Psychiatry. 1981 Apr;138(4):486-9. doi: 10.1176/ajp.138.4.486.

Abstract

The authors review the use of ECT with nine seriously depressed patients at the National Institute of Mental Health over the past 8 years. Despite the patients' poor prior response to a variety of pharmacological treatments, only one patient failed to show a complete response to ECT. With most patients, improvement was quite rapid and dramatic, and all of the ECT responders were free of depression for at least 1 year after treatment. These results are consistent with previous studies; they deserve reemphasis now in light of recent controversies over ECT, including legislative and judicial attempts to restrict its use.

MeSH terms

  • Adult
  • Aged
  • Amnesia, Retrograde / etiology
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Antipsychotic Agents / therapeutic use
  • Depressive Disorder / drug therapy
  • Depressive Disorder / therapy*
  • Drug Resistance
  • Electroconvulsive Therapy* / adverse effects
  • Female
  • Humans
  • Lithium / therapeutic use
  • Male
  • Middle Aged
  • Monoamine Oxidase Inhibitors / therapeutic use

Substances

  • Antidepressive Agents, Tricyclic
  • Antipsychotic Agents
  • Monoamine Oxidase Inhibitors
  • Lithium